Key facts
- This page summarizes Tamar D. Howson's Form 4 filing for MEI Pharma, Inc. (MEIP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Oct 2023, 19:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Such option shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in equal monthly amounts beginning October 1, 2023 and continuing on the first day of each calendar month following such date and continuing through July 1, 2024.